Biosino Bio-Technology and Science Inc
08247
Company Profile
Business description
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale and distribution of IVD reagent products. The company operates in single segment the in-vitro diagnostic reagent products segment, which manufactures, sells and distributes a variety of mono/double diagnostic reagent products. Geographically, it generates majority of the revenue from Mainland China.
Contact
No. 27 Chaoqian Road
Science and Technology Industrial Park
Changping District
Beijing102200
CHNT: +86 1080117700
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
471
Stocks News & Analysis
stocks
The best way to get rich and retire early
This goes through the different options including shares, property and business ownership and declares a winner, as well as outlining the mindset needed to earn enough to never have to work again.
stocks
Investors overly negative on cheap ASX share
We cut our fair value by 26% but the market has overreacted.
stocks
Overvalued US AI play reports earnings
Strong earnings with high projected growth but price is too rich.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,036.60 | 29.50 | 0.33% |
| CAC 40 | 8,169.58 | 20.08 | 0.25% |
| DAX 40 | 24,458.34 | 32.07 | -0.13% |
| Dow JONES (US) | 48,125.87 | 62.58 | 0.13% |
| FTSE 100 | 9,955.84 | 24.46 | 0.25% |
| HKSE | 26,338.47 | 707.93 | 2.76% |
| NASDAQ | 23,167.63 | 74.36 | -0.32% |
| Nikkei 225 | 50,339.48 | 187.44 | -0.37% |
| NZX 50 Index | 13,548.42 | 0.29 | 0.00% |
| S&P 500 | 6,836.12 | 9.38 | -0.14% |
| S&P/ASX 200 | 8,727.80 | 27.10 | 0.31% |
| SSE Composite Index | 3,968.84 | 3.72 | 0.09% |